Viracta Therapeutics Inc (VIRX)
0.47
-0.01
(-2.29%)
USD |
NASDAQ |
Jul 05, 16:00
0.47
0.00 (0.00%)
After-Hours: 19:04
Viracta Therapeutics Cash from Investing (Quarterly): 14.19M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.19M |
| December 31, 2023 | 9.27M |
| September 30, 2023 | 9.098M |
| June 30, 2023 | 3.98M |
| March 31, 2023 | -7.35M |
| December 31, 2022 | -0.203M |
| September 30, 2022 | -52.06M |
| June 30, 2022 | -1.606M |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.019M |
| September 30, 2021 | -4.228M |
| June 30, 2021 | -0.005M |
| March 31, 2021 | 17.14M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.005M |
| June 30, 2020 | -0.05M |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-52.06M
Minimum
Sep 2022
17.14M
Maximum
Mar 2021
-0.6965M
Average
-0.005M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| XOMA Corp | -7.246M |
| Marinus Pharmaceuticals Inc | 20.88M |
| Cartesian Therapeutics Inc | -0.602M |
| Adial Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.849M |
| Cash from Financing (Quarterly) | -6.598M |
| Free Cash Flow | -36.40M |
| Free Cash Flow Per Share (Quarterly) | -0.1996 |
| Free Cash Flow Yield | -199.4% |